Coenzyme Q10 could slow functional decline in Parkinson’s disease – (10-24-02)

Coenzyme Q10 could slow functional decline in Parkinson’s disease

A few interesting comments on this article. First, the highest therapeutic dose used in this study was 1200 mg…which is a pretty high dose as far as what I use in my office. Unfortunately, CoQ10 is not cheap and this would be prohibitive for many patients unless insurance covered some portion of it (dream on…). Interestingly, despite the fact that this study showed a clear benefit (44% reduction in worsening of symptoms) the authors still suggest “it would be premature for a PD patient to take these high doses until a phase III clinical trial is done.” Do you think a Parkinson’s patient who knows that progressive is inevitable would like to wait?

Effects of Coenzyme Q10 in Early Parkinson Disease: Evidence of Slowing of the Functional Decline.

Read entire article here

For more than a decade, Dr. Bogash has stayed current with the medical literature as it relates to physiology, disease prevention and disease management. He uses his knowledge to educate patients, the community and cyberspace on the best way to avoid and / or manage chronic diseases using lifestyle and targeted supplementation.







Email: